You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

~ Buy the EPIDUO (adapalene; benzoyl peroxide) Drug Profile, 2024 PDF Report in the Report Store ~

EPIDUO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Epiduo, and when can generic versions of Epiduo launch?

Epiduo is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in two NDAs. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-eight patent family members in twenty-five countries.

The generic ingredient in EPIDUO is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Drug patent expirations by year for EPIDUO
Drug Prices for EPIDUO

See drug prices for EPIDUO

Drug Sales Revenue Trends for EPIDUO

See drug sales revenues for EPIDUO

Recent Clinical Trials for EPIDUO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bausch Health Americas, Inc.Phase 2
BeiersdorfPhase 2
Mahidol UniversityPhase 2

See all EPIDUO clinical trials

Pharmacology for EPIDUO
Drug ClassRetinoid
Paragraph IV (Patent) Challenges for EPIDUO
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EPIDUO Gel adapalene; benzoyl peroxide 0.1%/2.5% 022320 1 2011-12-30

US Patents and Regulatory Information for EPIDUO

EPIDUO is protected by five US patents.

Patents protecting EPIDUO

Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Method for treatment of common acne
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: TREATMENT OF ACNE

Combinations of adapalene and benzoyl peroxide for treating acne lesions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: TREATMENT OF ACNE

Combinations of adapalene and benzoyl peroxide for treating acne lesions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: TREATMENT OF ACNE

Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: TREATMENT OF ACNE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EPIDUO

International Patents for EPIDUO

When does loss-of-exclusivity occur for EPIDUO?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 1989
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 07274288
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 0713182
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 56456
Estimated Expiration: ⤷  Try a Trial

China

Patent: 1541320
Estimated Expiration: ⤷  Try a Trial

Colombia

Patent: 50136
Estimated Expiration: ⤷  Try a Trial

Cyprus

Patent: 14473
Estimated Expiration: ⤷  Try a Trial

Patent: 21398
Estimated Expiration: ⤷  Try a Trial

Denmark

Patent: 46318
Estimated Expiration: ⤷  Try a Trial

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 46318
Estimated Expiration: ⤷  Try a Trial

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

France

Patent: 03603
Estimated Expiration: ⤷  Try a Trial

Hungary

Patent: 43502
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 09542779
Estimated Expiration: ⤷  Try a Trial

Patent: 14040481
Estimated Expiration: ⤷  Try a Trial

Patent: 16029094
Estimated Expiration: ⤷  Try a Trial

Lithuania

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 09000319
Estimated Expiration: ⤷  Try a Trial

Poland

Patent: 46318
Estimated Expiration: ⤷  Try a Trial

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

Portugal

Patent: 46318
Estimated Expiration: ⤷  Try a Trial

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

Russian Federation

Patent: 09104949
Estimated Expiration: ⤷  Try a Trial

Patent: 12136952
Estimated Expiration: ⤷  Try a Trial

Patent: 12144414
Estimated Expiration: ⤷  Try a Trial

Slovenia

Patent: 46318
Estimated Expiration: ⤷  Try a Trial

Patent: 50035
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 090028764
Estimated Expiration: ⤷  Try a Trial

Patent: 150003917
Estimated Expiration: ⤷  Try a Trial

Patent: 160120352
Estimated Expiration: ⤷  Try a Trial

Spain

Patent: 23951
Estimated Expiration: ⤷  Try a Trial

Patent: 03505
Estimated Expiration: ⤷  Try a Trial

Turkey

Patent: 1819658
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering EPIDUO around the world.

Country Patent Number Title Estimated Expiration
Luxembourg 85849 ⤷  Try a Trial
Australia 2008209730 Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris ⤷  Try a Trial
Israel 78463 6-PHENYL-2-NAPHTHALENE DERIVATIVES,THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM ⤷  Try a Trial
Argentina 065085 METODO PARA TRATAMIENTO PROLONGADO DEL ACNE VULGARIS ⤷  Try a Trial
Slovenia 1458369 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for EPIDUO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1458369 380 Finland ⤷  Try a Trial
1458369 08C0024 France ⤷  Try a Trial PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
1458369 CA 2008 00029 Denmark ⤷  Try a Trial PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
1458369 C01458369/01 Switzerland ⤷  Try a Trial PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009
1458369 122008000041 Germany ⤷  Try a Trial PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.